{"id":"https://openalex.org/W4308394685","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1359","title":"1359 Half-life extended engineered IL18 variants that escape the negative regulation of IL18BP","display_name":"1359 Half-life extended engineered IL18 variants that escape the negative regulation of IL18BP","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308394685","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1359"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.1359","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1359","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1359","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1410.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1410.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100637086","display_name":"Xiaofan Li","orcid":"https://orcid.org/0000-0002-4783-7372","observed_orcids":["https://orcid.org/0000-0002-4783-7372","https://orcid.org/0000-0003-3658-6480"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaofan Li","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022112792","display_name":"Cristina L. Abrahams","orcid":"https://orcid.org/0000-0003-4744-2343","observed_orcids":["https://orcid.org/0000-0003-4744-2343"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cristina Abrahams","raw_affiliation_strings":["Seagen, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seagen, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067262256","display_name":"Amandeep Gakhal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amandeep Gakhal","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101748842","display_name":"Junhao Yang","orcid":"https://orcid.org/0009-0003-5044-3424","observed_orcids":["https://orcid.org/0009-0003-5044-3424"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Junhao Yang","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072161368","display_name":"Kevin Brar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Brar","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005020873","display_name":"Daniel A. Calarese","orcid":"https://orcid.org/0000-0002-6941-7803","observed_orcids":["https://orcid.org/0000-0002-6941-7803"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Calarese","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088804767","display_name":"Robert A. Henningsen","orcid":"https://orcid.org/0000-0001-7656-509X","observed_orcids":["https://orcid.org/0000-0001-7656-509X"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Henningsen","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Grace Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grace Lee","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Katie Neighbors","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katie Neighbors","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055956090","display_name":"Jennifer S. Smith","orcid":"https://orcid.org/0000-0002-1256-0422","observed_orcids":["https://orcid.org/0000-0002-1256-0422","https://orcid.org/0000-0003-4171-511X"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Smith","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111567138","display_name":"Andrew McGeehan","orcid":"https://orcid.org/0009-0004-4998-3244","observed_orcids":["https://orcid.org/0009-0004-4998-3244"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew McGeehan","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003346545","display_name":"Millicent G. Embry","orcid":"https://orcid.org/0009-0007-2143-6179","observed_orcids":["https://orcid.org/0009-0007-2143-6179"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Millicent Embry","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104018917","display_name":"Abigail Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abigail Yu","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Alan Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Nguyen","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074310761","display_name":"Krishna Mohan Bajjuri","orcid":"https://orcid.org/0000-0002-5342-1381","observed_orcids":["https://orcid.org/0000-0002-5342-1381"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krishna Bajjuri","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Miao Wen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miao Wen","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100647740","display_name":"Young Joo Park","orcid":"https://orcid.org/0000-0002-3671-6364","observed_orcids":["https://orcid.org/0000-0002-3671-6364","https://orcid.org/0000-0002-8253-2881"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Young Park","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011177515","display_name":"Cuong Tran","orcid":"https://orcid.org/0000-0002-6425-3440","observed_orcids":["https://orcid.org/0000-0002-6425-3440"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cuong Tran","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035935036","display_name":"Mary Rose Masikat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Rose Masikat","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Gang Yin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gang Yin","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027822073","display_name":"Alice Yen-Wen Yam","orcid":"https://orcid.org/0000-0001-5650-6973","observed_orcids":["https://orcid.org/0000-0001-5650-6973"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice Yam","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030495022","display_name":"Kristin Bedard","orcid":"https://orcid.org/0000-0001-8067-7238","observed_orcids":["https://orcid.org/0000-0001-8067-7238"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristin Bedard","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073536299","display_name":"Trevor J. Hallam","orcid":"https://orcid.org/0000-0002-4621-3373","observed_orcids":["https://orcid.org/0000-0002-4621-3373"]},"institutions":[{"id":"https://openalex.org/I4210152259","display_name":"Sutro Biopharma (United States)","ror":"https://ror.org/05xybd718","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trevor Hallam","raw_affiliation_strings":["Sutro Biopharma, Inc., South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sutro Biopharma, Inc., South San Francisco, USA","institution_ids":["https://openalex.org/I4210152259"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1410","last_page":"A1410"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6675000190734863,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6675000190734863,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.14169999957084656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.06840000301599503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-18","display_name":"IL-18","score":0.9929999709129333},{"id":"https://openalex.org/keywords/half-life-extension","display_name":"half-life extension","score":0.7519999742507935},{"id":"https://openalex.org/keywords/ribosome-display","display_name":"ribosome display","score":0.7639999985694885},{"id":"https://openalex.org/keywords/pegylation","display_name":"PEGylation","score":0.6290000081062317},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.6190000176429749},{"id":"https://openalex.org/keywords/negative-feedback-regulation","display_name":"negative feedback regulation","score":0.5460000038146973},{"id":"https://openalex.org/keywords/protein-stability","display_name":"protein stability","score":0.5320000052452087},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.699999988079071},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6299999952316284},{"id":"https://openalex.org/keywords/cytokine-therapy","display_name":"cytokine therapy","score":0.4650000035762787},{"id":"https://openalex.org/keywords/site-directed-mutagenesis","display_name":"site-directed mutagenesis","score":0.6700000166893005}],"concepts":[{"id":"https://openalex.org/C68239362","wikidata":"https://www.wikidata.org/wiki/Q14907187","display_name":"Interleukin 18","level":3,"score":0.7365323901176453},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.5858561396598816},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.5240036249160767},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44269460439682007},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3222803473472595},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.19486886262893677},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17841440439224243},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1081584095954895},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.09056919813156128}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.1359","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1359","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1359","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1410.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.1359","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1359","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1359","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1410.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308394685.pdf","grobid_xml":"https://content.openalex.org/works/W4308394685.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393096988","https://openalex.org/W7148977285","https://openalex.org/W4411508222","https://openalex.org/W4282938565","https://openalex.org/W4404064377","https://openalex.org/W4308401724","https://openalex.org/W4308383977","https://openalex.org/W7220658998","https://openalex.org/W4244526808","https://openalex.org/W1980368409"],"abstract_inverted_index":{"Background":[0],"Interleukin-18":[1],"(IL18)":[2],"is":[3,51,72],"a":[4,52,80,177,194,379],"proinflammatory":[5],"cytokine":[6,385],"secreted":[7],"by":[8,268,278],"monocytes":[9],"and":[10,15,69,77,124,131,147,168,208,319,332,343,358,373,409],"macrophages":[11],"to":[12,25,59,90,190,193,203,221,245,250,258,286,308],"promote":[13],"T":[14,331,357],"NK":[16,333,359],"cells":[17,334,360],"activation.":[18],"While":[19],"wild":[20,41,96,251],"type":[21,42,97,252],"IL18":[22,43,47,56,60,66,75,84,98,103,117,135,159,165,175,213,216,246,262,296,306,328,353],"was":[23,37,140,181,200,275],"shown":[24],"be":[26],"efficacious":[27],"in":[28,32,44,99,118,152,187,223,294,323,335,348,387,394,399],"inhibiting":[29],"tumor":[30],"growth":[31],"animal":[33],"models,":[34],"limited":[35,92],"efficacy":[36,93,115],"observed":[38,94,257],"for":[39,55,83,95,149,164,383],"recombinant":[40],"clinical":[45],"trials.":[46],"binding":[48,151,220,237,243,256],"protein":[49,198],"(IL18BP)":[50],"decoy":[53],"receptor":[54,247],"that":[57,104,218],"binds":[58],"with":[61,401],"much":[62],"higher":[63,242],"affinity":[64,244],"than":[65],"receptors":[67],"(IL18Ra":[68],"IL18Rb).":[70],"IL18BP":[71,110,227,342],"up-regulated":[73],"upon":[74],"treatment":[76],"acts":[78],"as":[79],"negative":[81,107,364],"feedback":[82],"signaling":[85],"pathway,":[86],"which":[87,274,312],"likely":[88],"contributes":[89],"the":[91,106,114,153,172,188,205,224,231,239,287,295,305,310,315,336,363,402,405],"clinic.":[100,119],"Methods":[101],"Engineered":[102],"escape":[105],"regulation":[108,365],"of":[109,116,134,155,174,211,226,281,284,338,341,366,404],"could":[111],"greatly":[112],"improve":[113,204],"Sutro\u2019s":[120,351],"ribosome":[121,232],"display":[122,138,233],"technology":[123],"XpressCF":[125],"expression":[126],"platform":[127],"enabled":[128,298],"fast":[129],"engineering":[130,199],"testing":[132],"cycles":[133],"variants.":[136,214],"Ribosome":[137],"library":[139],"constructed":[141],"based":[142],"on":[143,304],"site":[144,186,293],"directed":[145],"mutations":[146,301],"selected":[148],"IL18Ra":[150,222],"presence":[154,225,337],"IL18BP.":[156,259,282,367],"The":[157,260,325,368],"resulting":[158],"variants":[160,217,240,263,307],"were":[161,228,302,397],"further":[162],"screened":[163],"pathway":[166],"activation":[167,361],"thermostability.":[169],"To":[170],"increase":[171],"half-life":[173,375],"variants,":[176],"non-natural":[178],"amino":[179],"acid":[180],"introduced":[182,303],"at":[183,413],"an":[184,291],"optimized":[185,292],"sequence":[189,297],"enable":[191],"conjugation":[192],"PEG":[195],"molecule.":[196],"Additional":[197,300],"also":[201,313],"employed":[202],"expression,":[206,316],"stability":[207,318],"PK":[209,346],"profile":[210,322,347],"our":[212],"Results":[215],"maintained":[219],"identified":[229,261],"from":[230,271],"library.":[234],"In":[235],"biacore":[236],"assay,":[238],"showed":[241],"(IL18Ra)":[248],"compared":[249],"IL18,":[253],"while":[254],"no":[255],"induced":[264],"potent":[265,356],"IFNg":[266],"secretion":[267],"human":[269],"PBMCs":[270],"healthy":[272],"donors,":[273],"not":[276],"affected":[277],"high":[279,339],"concentration":[280,340],"Conjugation":[283],"PEGs":[285],"nnAA":[288],"inserted":[289],"into":[290],"half-life-extension.":[299],"stabilize":[309],"molecule,":[311],"improved":[314],"thermal":[317],"serum":[320],"clearance":[321],"mice.":[324,349],"final":[326],"Sutro":[327,414],"lead":[329],"activates":[330],"exhibited":[344],"favorable":[345,369],"Conclusions":[350],"engineered":[352],"variant":[354],"induces":[355],"without":[362],"immune":[370],"stimulation,":[371],"pharmacokinetics":[372],"adjustable":[374],"extension":[376],"make":[377],"it":[378],"compelling":[380],"product":[381],"concept":[382],"future":[384],"therapy":[386],"broad":[388],"oncology":[389],"indications.":[390],"Ethics":[391],"Approval":[392],"All":[393],"vivo":[395],"procedures":[396],"conducted":[398],"compliance":[400],"guidelines":[403],"Institutional":[406],"Animal":[407],"Care":[408],"Use":[410],"Committee":[411],"(IACUC)":[412],"Biopharma":[415]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2022-11-11T00:00:00"}